Assessment findings that hold up in front of a regulator

Assessment findings that hold up in front of a regulator

Evidence is the difference between a finding and an opinion. In regulated industries, that distinction is not academic. A Health Canada auditor, an OSFI examiner, or an Ontario Energy Board reviewer will not accept a slide deck full of conclusions. They want to see the source data, the methodology, and the name of the person who signed off. If your SAP Implementation program cannot produce that chain of evidence, your findings are not findings. They are guesses dressed up in consulting language.

This matters more now than it did five years ago. AI tools can produce a detailed SAP environment analysis, covering custom object inventories, interface maps, and technical debt concentration, in a fraction of the time a manual assessment used to require. That speed is genuinely useful. However, speed without validation creates a new risk: AI-generated analysis that enters a program plan without a qualified human reviewing it. In regulated environments, that is a compliance exposure, not just a quality issue.

What Makes an Assessment Finding Defensible

A defensible assessment finding in a regulated SAP program has three properties: it is traceable to a source, it is attributed to a named reviewer, and it is reproducible. Any finding that lacks one of these properties will not survive a regulatory review in Canadian pharma, financial services, or utilities.

Traceability means you can point to the exact system record, configuration extract, or transport log that produced the finding. Attribution means a qualified professional, not a tool, has reviewed and accepted responsibility for the conclusion. Reproducibility means another qualified reviewer, given the same inputs, would reach the same conclusion.

These three properties are not bureaucratic overhead. They are the minimum standard that regulators in Canada expect when a company makes a material change to a core business system.

Why Regulated Industries Set a Higher Bar

Pharma companies operating under Health Canada's Good Manufacturing Practice guidelines must demonstrate that any system change was assessed, validated, and approved by a qualified person. Financial institutions under OSFI Guideline B-10 must show that technology risk assessments are documented and reviewed at an appropriate level of seniority. Utilities regulated by provincial energy boards must maintain audit trails for operational technology changes.

In each case, the regulator is not checking whether you used a good tool. They are checking whether a qualified human made a decision and documented it properly. That distinction shapes how every assessment finding must be structured.

How AI Changes the Speed of SAP Environment Analysis

AI tools have genuinely changed what is possible in the early stages of an SAP Implementation. A task that previously required weeks of manual extraction and spreadsheet analysis can now be completed in days. In a recent 2iSolutions engagement, AI produced an initial SAP environment analysis that covered a custom object inventory, an interface map, technical debt concentration, and modernization priorities. The speed and completeness of that output were significant.

However, the AI analysis was the starting point, not the deliverable. A senior architect at 2iSolutions reviewed every finding before it entered the program plan. That review step is not optional in a regulated environment. It is the step that converts AI output into a defensible assessment finding.

The Validation Layer That Cannot Be Skipped

The validation layer is where professional judgment enters the process. A senior architect reviewing an AI-generated interface map is not simply checking for errors. They are applying contextual knowledge about the client's industry, their regulatory obligations, and the downstream consequences of each finding.

For example, an AI tool might correctly identify a custom object as technically redundant. However, a senior architect might know that the object supports a reporting process tied to a specific regulatory submission. Removing it without that context would create a compliance gap. The AI found the object. The architect determined what to do with it.

This is why SAP Consulting and Implementation Services in regulated industries must always pair analytical tools with senior human oversight. The tool accelerates discovery. The expert makes the call.

Building the Evidence Chain for Each Finding

Every finding in a regulated SAP assessment should be documented with a consistent structure. The following elements are the minimum required to support regulatory scrutiny.

  1. Source reference: Identify the exact data source: a transport log, a configuration table, a system report, or a process document. The source must be retrievable and version-controlled.
  2. Finding statement: Write the finding in plain language. Avoid vague language like "suboptimal" or "legacy." State specifically what was found and where.
  3. Impact assessment: Describe the business or compliance consequence of the finding. Connect it to a specific regulatory requirement where applicable.
  4. Reviewer attribution: Record the name, role, and qualifications of the person who reviewed and accepted the finding. In pharma, this is often a qualified person under GMP guidelines.
  5. Disposition decision: Document whether the finding will be remediated, accepted as a risk, or deferred, and who made that decision.
  6. Sign-off date: Record when the finding was approved. Regulators frequently check whether assessments were completed before or after a system change.

This structure applies whether the finding was generated by a manual review or an AI-assisted analysis. The source of the finding does not change the documentation standard.

Handling Technical Debt Findings Specifically

Technical debt findings deserve special attention in regulated environments. Technical debt, in SAP terms, refers to accumulated customizations, workarounds, and outdated configurations that increase system complexity and risk over time. Regulators do not use the term "technical debt," but they do care about its consequences: undocumented changes, unsupported configurations, and system behaviours that cannot be explained.

When an assessment identifies technical debt concentration in a specific area, the finding must be specific enough to act on. "High technical debt in the finance module" is not a finding. "Forty-seven custom enhancements in the accounts payable area, of which twelve have no associated functional specification" is a finding. The second version can be traced, attributed, and acted upon.

Structuring Findings for Different Regulatory Audiences

Not every regulator reads the same way. A finding that satisfies an internal audit committee may not satisfy a Health Canada inspector. Structuring findings for the right audience is part of producing assessment work that holds up.

In pharma, the audience is a qualified person and, potentially, a Health Canada inspector. Findings must connect directly to validated system functions. Any finding that touches a GxP process must reference the relevant validation documentation.

In financial services, the audience is often an OSFI examiner or an internal model risk team. Findings must connect to specific risk categories and show that a qualified reviewer assessed the materiality of each issue. OSFI's 2023 Guideline B-10 explicitly requires that technology risk assessments be proportionate to the risk and reviewed at an appropriate governance level.

In utilities, the audience may be a provincial energy board or an internal reliability team. Findings related to operational technology integration, particularly where SAP connects to SCADA or asset management systems, must show that operational risk was assessed alongside IT risk.

Matching the Finding Format to the Governance Structure

The format of a finding should match the governance structure of the organization. A finding destined for a board risk committee needs a different level of abstraction than one going to a technical remediation team. Both versions must be traceable to the same underlying evidence. However, the board version summarizes the business consequence, while the technical version details the specific configuration or code issue.

Producing both versions from a single evidence base is a discipline that separates mature assessment practices from ad hoc ones. It also makes regulatory review faster, because the regulator can move between the summary and the detail without encountering gaps. For broader context when comparing governance and delivery assumptions, consult Canadian SME research reports.

Choosing the Right SAP Implementation Partner for Regulated Environments

Selecting a SAP Implementation Partner for a regulated industry program is not the same as selecting one for a commercial deployment. The partner needs to understand both the technical requirements of the SAP platform and the documentation standards of the relevant regulator.

The right partner will ask, early in the engagement, how findings will be used. Will they support a regulatory submission? Will they be reviewed by an external auditor? Will they form the basis of a validation protocol? The answers to those questions shape how the assessment is structured from the start.

2iSolutions works specifically in this space. The firm brings senior architects who understand both SAP Implementation Services and the compliance requirements of Canadian regulated industries. That combination is less common than it should be. Many firms are strong on the technical side but unfamiliar with what a Health Canada inspector or an OSFI examiner actually looks for in an assessment document.

When evaluating partners, ask specifically about their experience documenting findings for regulatory review. Ask for examples of assessment deliverables that have been reviewed by a regulator. Ask how they handle the validation of AI-generated analysis. Those questions will quickly separate firms with genuine regulated-industry experience from those without it.

Frequently Asked Questions

Q. What is the minimum documentation standard for an SAP assessment finding in a regulated Canadian industry?

A. At minimum, each finding must include a traceable source reference, a plain-language finding statement, an impact assessment connected to a specific regulatory requirement, and a named reviewer who accepted responsibility for the conclusion. In pharma, a qualified person under GMP guidelines must sign off. In financial services, OSFI expects findings to be reviewed at a governance level proportionate to the risk.

Q. Can AI-generated analysis be used in a regulated SAP assessment?

A. Yes, but only when a qualified human reviews and validates every finding before it enters a program plan or regulatory submission. AI tools can accelerate discovery significantly. However, the regulatory standard requires human attribution and professional judgment. The tool produces the analysis; the expert takes responsibility for the conclusion.

Q. How should technical debt findings be documented to satisfy a regulator?

A. Technical debt findings must be specific and traceable. A finding like "high technical debt in the finance module" will not satisfy a regulator. Instead, document the exact number of custom objects, identify which ones lack functional specifications, and connect each gap to a specific compliance or operational risk. Vague findings invite follow-up questions that slow down regulatory review.

Q. What makes 2iSolutions different when delivering assessments for regulated industries?

A. 2iSolutions pairs AI-assisted environment analysis with senior architect validation, ensuring that every finding entering a program plan has been reviewed by a qualified professional. The firm understands both the technical requirements of SAP programs and the documentation standards that Canadian regulators expect in pharma, financial services, and utilities.

Q. How does SAP Ariba implementation affect assessment documentation in a regulated environment?

A. SAP Ariba implementation introduces procurement process complexity that regulators in pharma and financial services scrutinize closely. Supplier qualification workflows, contract compliance controls, and procurement audit trails must all be assessed and documented with the same rigor as core ERP functions. Any finding related to Ariba integration should reference the specific procurement compliance requirement it affects.

Conclusion

Assessment findings that survive regulatory scrutiny are not produced by better tools alone. They are produced by a disciplined process that connects every conclusion to a traceable source, assigns it to a named reviewer, and documents the decision that followed. AI has made the discovery phase of an SAP Implementation faster and more complete. That is a real advantage. However, the validation layer, where a senior professional reviews each finding and takes responsibility for it, remains the step that determines whether the work holds up in front of a regulator.

Canadian regulated industries operate under specific and demanding documentation standards. Health Canada, OSFI, and provincial energy boards each have their own expectations, but they share a common requirement: a qualified human made the call and documented it properly. Firms that treat assessment documentation as an afterthought will find that out the hard way during a regulatory review.

2iSolutions brings together the analytical capability to move quickly and the senior expertise to validate findings to the standard that Canadian regulators expect. For organizations planning a regulated SAP program, that combination is not a nice-to-have. It is the baseline for producing assessment work that actually holds up.

Schedule an AI Discovery Session.: Link